ยากันชักเหนี่ยวนำให้เกิดความผิดปกติทางสายตา
คำสำคัญ:
โรคลมชัก, ยากันชัก, ความผิดปกติทางการมองเห็น, ขนาดยาที่ใช้ในการรักษาบทคัดย่อ
โรคลมชัก คือ โรคความผิดปกติทางสมองซึ่งนำไปสู่การเกิดภาวะแทรกซ้อน ยากันชักมีบทบาทที่สำคัญใช้ในการรักษาโรคลมชัก อย่างไรก็ตาม ยากันชักเป็นยาที่มีดัชนีการรักษาแคบและไม่เฉพาะเจาะจงต่อเซลล์ประสาทที่ก่อให้เกิดการชักเท่านั้น ยานี้อาจมีผลต่ออวัยวะอื่นๆ เช่น เหนี่ยวนำให้เกิดความผิดปกติทางการมองเห็น ซึ่งปัจจุบันข้อมูลมีค่อนข้างจำกัด กลไกการเกิดยังไม่ชัดเจน บทความนี้นำข้อมูลที่เกี่ยวข้องกับการเกิดความผิดปกติทางการมองเห็นจากการได้รับยาในขนาดการรักษาและวินิจฉัยกลไกที่อาจเป็นสาเหตุของการเกิดในแต่ละอาการ คาดว่าข้อมูลนี้จะเป็นประโยชน์ต่อบุคลากรการแพทย์ในการดูแลผู้ป่วยโรคลมชักและเข้าใจการเกิดความผิดปกติทางการมองเห็น
เอกสารอ้างอิง
Lukasiewicz PD, Shields CR. A diversity of GABA receptors in the retina. Semin Cell Dev Biol 1998;9(3):293–9.
Yang XL. Characterization of receptors for glu-tamate and GABA in retinal neurons. Neurobiol 2004;73(2):127–50.
Hilton EJR, Hosking SL, Betts T. The effect of antiepileptic drugs on visual performance. Seizure. 2004;13:113–28.
Logba A, Horowitz BZ. Phenytoin toxicity [Internet]. 2020 [cited 2020 Jul 29]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482444/.
Wu D, Thijs RD. Anticonvulsant-induced downbeat nystagmus in epilepsy. Epilepsy Behav Case Rep 2015;4:74–5.
Wirfs L, Whitworth K, Kellar J. Nystagmus associ-ated with carbamazepine toxicity. Clin Pract Cases Emerg Med 2017;1(4):441–2.
Puri V, Chaudhry N. Total external ophthalmo-plegia induced by phenytoin: a case report and review of literature. Neurology India 2004;52(3): 386–7.
Halpern LM, Julien RM. Augmentation of cerebellar Purkinje cell discharge rate after diphenylhydantoin. Epilepsia 1972;13(3):377-85.
Kalume F, Yu FH, Westenbroek RE, Scheuer T, Catterall WA. Reduced sodium current in Purkinje neurons from NaV1.1 mutant mice: implications for ataxia in severe myoclonic epilepsy in infancy. J Neurosci 2007;27(41):11065–74.
Najem K, Margolin E. Diplopia [Internet]. 2020 [cited 2020 Jul 14]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441905/.
Han H, Qu W, Kang H, Hu X, Zhen G, Zhu S, et al. Effect of second-generation antiepileptic drugs on diplopia: a meta studies analysis of place-bo-controlled. J Huazhong Univ Sci Techno Med Sci 2012;32(4):557–62.
Matsuo F, Gay P, Madsen J, Tolman KG, Roll-ins DE, Risner ME, et al. Lamotrigine high-dose tolerability and safety in patients with epilepsy: a double-blind, placebo-controlled, even-week study. Epilepsia 1996;37(9):857–62.
Behbehani R. Clinical approach to optic neuropa-thies. Clin Ophthalmol 2007;1(3):233–46.
Pelli DG, Bex P. Measuring contrast sensitivity. Vision Res 2013;90:10–4.
U.S.National Library of Medicine. Color vision deficiency [Internet]. 2020 [cited 19 May 2020]. Available from: http://ghr.nlm.nih.gov/condition/color-vision-deficiency
DRUGDEX System (database on the internet). Ann Arbor (MI): Truven Health Analytics. Phenytoin [In-ternet]. 2020 [cited 17 May 2020]. Available from: www.micromedexsolutions.com
DRUGDEX System (database on the internet). Ann Arbor (MI): Truven Health Analytics. Carbamaze-pine [Internet]. 2020 [cited 17 May 2020]. Available from: www.micromedexsolutions.com
Bayer AU, Thiel HJ, Zrenner E, Dichgans J, Kuehn M, Paulus W, et al. Color vision tests for early detection of antiepileptic drug toxicity. Neurology 1997;48(5):1394–7.
Nousiainen I, Kälviäinen R, Mäntyjärvi M. Color vision in epilepsy patients treated with vigabatrin or carbamazepine monotherapy. Ophthalmology 2000;107(5):884–8.
Manuchehri K, Goodman S, Siviter L, Nightingale S. A controlled study of vigabatrin and visual ab-normalities. Br J Ophthalmol 2000;84:499–505.
Nousiainen I, Kälviäinen R, Mäntyjärvi M. Contrast and glare sensitivity in epilepsy patients treated with vigab-atrin or carbamazepine monotherapy compared with healthy volunteers. Br J Ophthalmol 2000;84(6):622–5.
Daneshvar H, Racette L, Coupland SG, Kertes PJ, Guberman A, Zackon D. Symptomatic and asymptomatic visual loss in patients taking vigab-atrin. Ophthalmology 1999;106(9):1792–8.
Sorri I. Effects of antiepileptic drugs on visual function, with special reference to vigabatrin. Acta Ophthalmologica Scandinavica 2002;80(3):343–4.
Homma K, Wakakura M, Ishikawa S. A case of phenobarbital-induced optic neuropathy. Neu-ro-ophthalmology 1989;9(6):357–60.
Kar SK, Borasi M, Kumar D, Gupta SK. Carbamaz-epine induced optic neuropathy in an adolescent boy with conduct disorder: a rare case report. Indian J Psychiatry 2015;57(4):437–8.
Weinreb RN, Aung T, Medeiros FA. The patho-physiology and treatment of glaucoma a review. JAMA 2014;311(18):1901–11.
Langtry HD, Gillis JC, Davis R. Topiramate. a re-view of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy. Drugs 1997;54(5):752–73.
Dodgson SJ, Shank RP, Maryanoff BE. Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia 2000;41(1):35–9.
Yang MC, Lin KY. Drug-induced acute angle-clo-sure glaucoma: a review. J Curr Glaucoma Pract 2019;13(3):104–9.
Aminlari A, East W, Wei W, Quillen D. Topiramate induced acute angle closure glaucoma. Open Oph-thalmol J 2008;2:46–7.
Craig JE, Ong TJ, Louis DL, Wells JM. Mecha-nism of topiramate-induced acute-onset myopia and angle closure glaucoma. Am J Ophyhalmol 2004;137(1):193–5.
Krieg PH, Schipper I. Drug-induced ciliary body oede-ma: a new theory. Eye (Lond) 1996;10(1):121–6.
Sankar PS, Pasquale LR, Grosskreutz CL. Uveal effusion and secondary angle-closure glaucoma associated with topiramate use. Arch Ophthalmol 2001;119(8):1210–1.
Bhattacharyya KB, Basu S. Acute myopia induced by topiramate: report of a case and review of the literature. Neurol India 2005;53(1):108–9.
Boonyaleephan S. Bilateral acute onset myopia and angle closure glaucoma after oral topiramate: a case report. J Med Assoc Thai 2008;91(12):1904–7.
Rapoport Y, Benegas N, Kuchtey RW, Joos KM. Acute myopia and angle closure glaucoma from topiramate in a seven-year-old: a case report and review of the literature. BMC Pediatr 2014; 14:96.
Weiler DL. Zonisamide-induced angle closure and myopic Shift. Optom Vis Sci 2015;92(2):e45–51.
Lee GC, Tam CP, Danesh-Meyer HV, Myers JS, Katz LJ. Bilateral angle closure glaucoma induced by sulphonamide-derived medications. Clin Exp Ophthalmol 2007;35(1):55–8.
O’Brien J, Taylor JP, Ballard C, Barker RA, Bradley C, Burns A, et al. Visual hallucinations in neurologi-cal and ophthalmological disease: pathophysiology and management. J Neurol Neurosurg Psychiatry 2020;91:512–9.
Parsons KA, Derkits ME. Visual hallucinations asso-ciated with gabapentin use. Am J Health-Syst Pharm 2016;73:631–4.
Mousailidis G, Papanna B, Salmon A, Sein A, Al-Hilla-wi Q. Pregabalin induced visual hallucinations—a rare adverse reaction. BMC Pharmacol Toxicol 2020;21(16):1–4.
Jaffe MJ, Hommer DW, Caruso RC, Straw GM, de Monasterio FM. Attenuating effects of diazepam on the electroretinogram of normal humans. Retina 1989;9(3):216–25.
Young YH, Huang TW. Role of clonazepam in the treatment of idiopathic downbeat nystagmus. Laryngoscope 2001;111(8):1490–3.
Lucca JM, Ramesh M, Parthasarathi G, Ram D. Lorazepam-induced diplopia. Indian J Pharmacol 2014;46(2):228–9.
DRUGDEX System (database on the internet). Ann Arbor (MI): Truven Health Analytics. Phenobarbi-tone [Internet]. 2020 [cited 17 May 2020]. Available from: www.micromedexsolutions.com
Thakral A, Shenoy R, Deleu D. Acute visual dys-function following phenytoin-induced toxicity. Acta neurol belg 2003;103:218–20.
Bayer A, Thiel HJ, Zrenner E, Paulus W, Ried S, Schmidt D. Disorders of color perception and increase glare sensitivity in phenytoin and carba-mazepine therapy. ocular side effects of anticon-vulsants. Nervenarzt 1995;66(2):89–96.
Chew SH, Looi I, Lo Yl, Lim KS. Phenytoin toxicity presenting with acute visual loss and acute delirium, a case report. Neurology Asia 2018;23(4):363–5.
Marin LL, García-Peñas JJ, Herguedas JL, Gutiérrez-Solana LG, Ruiz-Falcó M, Rodriguez AD, et al. Phenytoin-induced visual disturbances mim-icking delirium tremens in a child. Eur J Paediatr Neurol 2010;14(5):460–3.
DRUGDEX System (database on the internet). Ann Arbor (MI): Truven Health Analytics. Primidone [Internet]. 2020 [cited 17 May 2020]. Available from: www.micromedexsolutions.com
Schwankhaus JD, Kattah JC, Lux WE, Masucci EF, Kurtzke JF. Primidone/phenobarbital-induced periodic al-ternating nystagmus. Ann Ophthalmol 1989;21(6):230–2.
Matthew TJH, Tharakarn J, Tai E, Hussein A. Study of visual function in adult epileptic patients on sodium valproate or carbamazepine monotherapy. Cureus 2019;11(4):1–8.
Ozkul Y, Gurler B, Uckardes A, Bozlar S. Visual functions in epilepsy patients on valproate mono-therapy. J Clin Neurosci 2002;9(3):247–50.
DRUGDEX System (database on the internet). Ann Arbor (MI): Truven Health Analytics. Valproic acid [Internet]. 2020 [cited 17 May 2020]. Available from: www.micromedexsolutions.com
Rev E. Vigabatrin-associated visual field loss: past, present and future. Ophthalmol 2014;9(3):145–8.
Lawden MC, Eke T, Degg C, Harding GFA, Wild JM. Visual field defects associated with vigabatrin therapy. J Neurol Neurosurg Psychiatry 1999;67: 716–22.
DRUGDEX System (database on the internet). Ann Arbor (MI): Truven Health Analytics. Vigabatrin [In-ternet]. 2020 [cited 17 May 2020]. Available from: www.micromedexsolutions.com
Kalis M, Huff NA. Oxcarbazepine, an antiepileptic agents. Clin Ther 2001;23(5):680–700.
Akta Z, Cansu A, Erdogan D, Take G, Goktas G, Ozdek S, et al. Retinal ganglion cell toxicity due to oxcarbazepine and valproic acid treatment in rat. Seizure 2009;18:396–9.
DRUGDEX System (database on the internet). Ann Arbor (MI): Truven Health Analytics. Oxcarbazepine [Internet]. 2020 [cited 17 May 2020]. Available from: www.micromedexsolutions.com
DRUGDEX System (database on the internet). Ann Arbor (MI): Truven Health Analytics. Lamotrigine [Internet]. 2020 [cited 17 May 2020]. Available from: www.micromedexsolutions.com
Bekkelund Sl, Lilleng H, Tonseth S. Gabapentin may cause reversible visual field constriction. BMJ 2006;332(7556):1511.
Kim JY, Kim DG, Kim SH, Kwon WO, Kim SH, You YS. Macular edema after gabapentin. Korean J Ophthalmol 2016;30(2):153–5.
DRUGDEX System (database on the internet). Ann Arbor (MI): Truven Health Analytics. Gabapentin [Internet]. 2020 [cited 17 May 2020]. Available from: www.micromedexsolutions.com
DRUGDEX System (database on the internet). Ann Arbor (MI): Truven Health Analytics. Felbamate [In-ternet]. 2020 [cited 17 May 2020]. Available from: www.micromedexsolutions.com
Shi LL, Dong J, Ni H, Geng J, Wu T. Felbamate as an add-on therapy for refractory partial ep-ilepsy (review). Cochrane Database Syst Rev 2017;7(7):CD008295.
Abtahi MA, Abtahi SH, Fazel F, Roomizadeh P, Etemadifar M, Jenab K, et al. Topiramate and the vision: a systematic review. Clin Ophthalmol 2012;6:117–31.
Gawley SD. Topiramate induced acute transient myopia: a case report. Cases J 2009;2:7430.
DRUGDEX System (database on the internet). Ann Arbor (MI): Truven Health Analytics. Topiramate [Internet]. 2020 [cited 17 May 2020]. Available from: www.micromedexsolutions.com
DRUGDEX System (database on the internet). Ann Arbor (MI): Truven Health Analytics. Tiagabine [In-ternet]. 2020 [cited 17 May 2020]. Available from: www.micromedexsolutions.com
Erdogan S, Bosnak M. Hallucination: a rare complication of levetiracetam theraphy. North Clin Istanb 2017;4(3):267–9.
Durgut BD, Turk A, Arslan EA, Kamasak T, Sahin S, Dilber B, et al. An investigation of the ocular toxic effects of levetiracetam therapy in children with epilepsy. Childs Nerv Syst 2019;35:769–74.
DRUGDEX System (database on the internet). Ann Arbor (MI): Truven Health Analytics. Levetiracetam [Internet]. 2020 [cited 17 May 2020]. Available from: www.micromedexsolutions.com
DRUGDEX System (database on the internet). Ann Arbor (MI): Truven Health Analytics. Pregabalin [Internet]. 2020 [cited 17 May 2020]. Available from: www.micromedexsolutions.com
Akman Cl, Goodkin HP, Rogers DP, Riviello Jr JJ. Visual hallucinations associated with zonisamide. Pharmacotherapy. 2003;23(1):93–6.
DRUGDEX System (database on the internet). Ann Arbor (MI): Truven Health Analytics. Zonisamide [Internet]. 2020 [cited 17 May 2020]. Available from: www.micromedexsolutions.com
Wirrel EC, Laux L, Franz DN, Sullivan J, Saneto RP, Morse RP, et al. Stiripentol in dravet syndrome: results of a retrospective U.S. study. Epilepsia 2013;54(9):1595–604.
DRUGDEX System (database on the internet). Ann Arbor (MI): Truven Health Analytics. Stiripentol [Internet]. 2020 [cited 17 May 2020]. Available from: www.micromedexsolutions.com
DRUGDEX System (database on the internet). Ann Arbor (MI): Truven Health Analytics. Perampanel [Internet]. 2020 [cited 17 May 2020]. Available from: www.micromedexsolutions.com
DRUGDEX System (database on the internet). Ann Arbor (MI): Truven Health Analytics. Lacosamide [Internet]. 2020 [cited 17 May 2020]. Available from: www.micromedexsolutions.com
DRUGDEX System (database on the internet). Ann Arbor (MI): Truven Health Analytics.Eslicarbazepine [Internet]. 2020 [cited 17 May 2020]. Available from: www.micromedexsolutions.com
ดาวน์โหลด
เผยแพร่แล้ว
เวอร์ชัน
- 2026-02-04 (2)
- 2022-12-28 (1)
ฉบับ
บท
การอนุญาต
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความที่ได้รับการตีพิมพิ์เป็นลิขสิทธิ์ของวารสารโรงพยาบาลชลบุรี